Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Favipiravir plus hydroxychloroquine versus hydroxychloroquine in hospitalized adults with COVID-19
MOH_2020-04-13_008847Phase 2Recruiting
- Sponsor
- פרופר רן ניר פז
- Start
- Apr 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, open-label trial in coronavirus disease 2019 (COVID-19) comparing Hydroxychloroquine plus usual care with Favipiravir plus hydroxychloroquine plus usual care (2 arms). Started Apr 2020; status: recruiting.
02
Drugs
favipiravirhydroxychloroquine
03
Conditions
coronavirus disease 2019 (COVID-19)
Beyond the preview
Go deeper on MOH_2020-04-13_008847.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on MOH_2020-04-13_008847.